InvestorsHub on MSN
BioVaxys posts encouraging ovarian cancer data from MVP-S combo trial
BioVaxys Technology Corp. (CSE:BIOV) (USOTC:BVAXF) said it has reported positive early results from its Phase 1B/2 PESCO ...
Stocktwits on MSN
Moderna stock still worth 37% less after cancer vaccine data? BofA’s new price target keeps retail traders cautious
BofA lifted its price target to $27 from $24 while keeping an 'Underperform' rating on the shares. ・The update followed the ...
The American Cancer Society’s latest Cancer Statistics report reveals that the U.S. five-year survival rate for all cancers ...
The most striking finding in recent oncological research is the significant gain in survival rates for cancers previously ...
The five-year relative survival for all cancers combined has reached a milestone, according to the American Cancer Society.
Survival rates for all cancers are increasing, but threats to federal funding and access to care jeopardize these advances.
Cancer survival has reached a record 70% nationwide, but Texas accounts for the third-largest share of U.S. cancer cases and ...
Live Science on MSN
Color blindness linked to lower bladder cancer survival, early study hints
People with color blindness may be less able to spot an early sign of bladder cancer, making them likelier to be diagnosed ...
Researchers have turned artificial intelligence into a powerful new lens for understanding why cancer survival rates differ ...
Earlier this week, the American Cancer Society (ACS) published its annual report in CA: A Cancer Journal for Clinicians. Each year, a team of doctors | Cancer ...
Bengaluru: The hospital-based cancer registry data from state-run Kidwai Memorial Institute of Oncology (KMIO), one of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results